Joakim Crona

Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

Backman, Samuel; Axling, Fredrik; Zhang, Liang; Botling, Johan et al.

Part of Endocrine pathology, 2026

• DOI for Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma
• Download full text (pdf) of Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

Vyakaranam, Achyut Ram; Norlén, Olov; Akural, Alina; Crona, Joakim et al.

Part of Journal of neuroendocrinology, 2026

• DOI for ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.
• Download full text (pdf) of ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Mollazadegan, Kazhan; Botling, Johan; Skogseid, Britt; Eriksson, Barbro et al.

Part of Journal of neuroendocrinology, 2025

• DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
• Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy

De Mestier, Louis; Halfdanarson, Thorvardur R.; Apostolidis, Leonidas; Koumarianou, Anna et al.

Part of Endocrine pathology, 2025

• DOI for Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy

Efficacy of immune checkpoint inhibitors (ICI) in patients with advanced pancreatic NETs displaying high TMB and MMR alterations following treatment with alkylating agents

de Mestier, L.; Apostolidis, L.; Koumarianou, A.; Cubero, J. Hernando et al.

Part of Journal of neuroendocrinology, 2025

Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

Backman, Samuel; Axling, Fredrik; Zhang, Liang; Botling, Johan et al.

Part of Endocrine pathology, 2026

• DOI for Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma
• Download full text (pdf) of Genomic Catastrophe Defines the Evolutionary Trajectory of Adrenocortical Carcinoma

¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

Vyakaranam, Achyut Ram; Norlén, Olov; Akural, Alina; Crona, Joakim et al.

Part of Journal of neuroendocrinology, 2026

• DOI for ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.
• Download full text (pdf) of ¹¹C-Hydroxyephedrine PET/CT for preoperative surgical planning in large pheochromocytoma and paraganglioma.

The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Mollazadegan, Kazhan; Botling, Johan; Skogseid, Britt; Eriksson, Barbro et al.

Part of Journal of neuroendocrinology, 2025

• DOI for The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study
• Download full text (pdf) of The impact of re-characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy

De Mestier, Louis; Halfdanarson, Thorvardur R.; Apostolidis, Leonidas; Koumarianou, Anna et al.

Part of Endocrine pathology, 2025

• DOI for Immunotherapy for Metastatic Pancreatic Neuroendocrine Tumors with High Mutational Burden and Mismatch Repair Alterations Following Treatment with Alkylating Chemotherapy

Efficacy of immune checkpoint inhibitors (ICI) in patients with advanced pancreatic NETs displaying high TMB and MMR alterations following treatment with alkylating agents

de Mestier, L.; Apostolidis, L.; Koumarianou, A.; Cubero, J. Hernando et al.

Part of Journal of neuroendocrinology, 2025

Feasibility and outcome of genomics-guided treatment selection in advanced cancer: the MEGALiT explorative clinical trial

Ny, Lars; Fagman, Henrik; Botling, Johan; Mantovaara, Loviisa et al.

Part of Acta Oncologica, p. 742-750, 2025

• DOI for Feasibility and outcome of genomics-guided treatment selection in advanced cancer: the MEGALiT explorative clinical trial
• Download full text (pdf) of Feasibility and outcome of genomics-guided treatment selection in advanced cancer: the MEGALiT explorative clinical trial

Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles

Flynn, Aidan; Pattison, Andrew D.; Balachander, Shiva; Boehm, Emma et al.

Part of Nature Communications, 2025

• DOI for Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles
• Download full text (pdf) of Multi-omic analysis of SDHB-deficient pheochromocytomas and paragangliomas identifies metastasis and treatment-related molecular profiles

Reinventing ESMO after the COVID-19 pandemic: moving towards a sustainable academic society

Crona, Joakim; Lee, R.; Sobczuk, P.; Wysoki, O. et al.

Part of ESMO Open, 2024

• DOI for Reinventing ESMO after the COVID-19 pandemic: moving towards a sustainable academic society
• Download full text (pdf) of Reinventing ESMO after the COVID-19 pandemic: moving towards a sustainable academic society

Diagnosis and management of urinary bladder paragangliomas: A Sino-American-European retrospective observational study

Pang, Yingxian; Zhang, Jing; Jiang, Jingjing; Pamporaki, Christina et al.

Part of Clinical Endocrinology, p. 234-242, 2024

• DOI for Diagnosis and management of urinary bladder paragangliomas: A Sino-American-European retrospective observational study

Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers

Algeri, L.; Falkman, Lovisa; Spada, F.; Frassoni, S. et al.

Part of ESMO Open, 2024

• DOI for Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers
• Download full text (pdf) of Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers

The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Backman, Samuel; Botling, Johan; Nord, Helena; Ghosal, Suman et al.

Part of Journal of Pathology, p. 357-370, 2024

• DOI for The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation
• Download full text (pdf) of The evolutionary history of metastatic pancreatic neuroendocrine tumours reveals a therapy driven route to high-grade transformation

Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Falkman, Lovisa; Sundin, Anders; Skogseid, Britt; Botling, Johan et al.

Part of Upsala Journal of Medical Sciences, 2024

• DOI for Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors
• Download full text (pdf) of Genetics-guided therapy in neuroendocrine carcinoma: response to BRAF- and MEK-inhibitors

Response to Letter to the Editor regarding 'Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma'

Zhang, Liang; Åkerström, Tobias; Mollazadegan, Kazhan; Beuschlein, Felix et al.

Part of Endocrine-Related Cancer, 2024

• DOI for Response to Letter to the Editor regarding 'Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma'

Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma

Zhang, Liang; Åkerström, Tobias; Mollazadegan, Kazhan; Beuschlein, Felix et al.

Part of Endocrine-Related Cancer, 2023

• DOI for Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma
• Download full text (pdf) of Risk of complications after core needle biopsy in pheochromocytoma/paraganglioma

Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

Ghosal, Suman; Vanova, Katerina Hadrava; Uher, Ondrej; Das, Shaoli et al.

Part of Endocrine, p. 171-179, 2023

• DOI for Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

Kjaer, Josefine; Smith, Sara; Hellman, Per; Stålberg, Peter et al.

Part of World Journal of Surgery, p. 340-347, 2023

• DOI for Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation
• Download full text (pdf) of Overall Survival in Patients with Stage IV Pan-NET Eligible for Liver Transplantation

Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Mollazadegan, Kazhan; Skogseid, Britt; Botling, Johan; Åkerström, Tobias et al.

Part of Endocrine Connections, 2022

• DOI for Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors
• Download full text (pdf) of Poor outcome after systemic therapy in secondary high-grade pancreatic neuroendocrine tumors

Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Kjaer, Josefin; Clancy, Thomas E.; Thornell, Anders; Andersson, Niklas et al.

Part of Annals of Surgery Open, 2022

• DOI for Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
• Download full text (pdf) of Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study

Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment

Lamarca, Angela; Cives, Mauro; de Mestier, Louis; Crona, Joakim et al.

Part of World Journal of Gastroenterology, p. 976-989, 2021

• DOI for Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3(rd)-line treatment

Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.

Pettersson, Olof; Fröss-Baron, Katarzyna; Crona, Joakim; Sundin, Anders

Part of Endocrine Connections, p. 422-431, 2021

• DOI for Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.
• Download full text (pdf) of Tumor growth rate in pancreatic neuroendocrine tumor patients undergoing PRRT with 177Lu-DOTATATE.

High-Specific-Activity-¹³¹I-MIBG versus ¹⁷⁷Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma

Jha, Abhishek; Taïeb, David; Carrasquillo, Jorge A.; Pryma, Daniel A. et al.

Part of Clinical Cancer Research, p. 2989-2995, 2021

• DOI for High-Specific-Activity-¹³¹I-MIBG versus ¹⁷⁷Lu-DOTATATE Targeted Radionuclide Therapy for Metastatic Pheochromocytoma and Paraganglioma

Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability

Dromain, Clarisse; Sundin, Anders; Najran, Pavan; Vidal Trueba, Hector et al.

Part of Neuroendocrinology, p. 831-839, 2021

• DOI for Tumour Growth Rate to predict the outcome of patients with Neuroendocrine Tumours: Performance and sources of variability

Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases

Kjaer, Josefin; Stålberg, Peter; Crona, Joakim; Welin, Staffan et al.

Part of BJS Open, 2021

• DOI for Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases
• Download full text (pdf) of Long-term outcome after resection and thermal hepatic ablation of pancreatic neuroendocrine tumour liver metastases

Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension

Lenders, Jacques W. M.; Kerstens, Michiel N.; Amar, Laurence; Prejbisz, Aleksander et al.

Part of Journal of Hypertension, p. 1443-1456, 2020

• DOI for Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension

Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Pettersson, Olof; Fröss-Baron, Katarzyna; Crona, Joakim; Sundin, Anders

Part of Frontiers in Oncology, 2020

• DOI for Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients
• Download full text (pdf) of Tumor Contrast-Enhancement for Monitoring of PRRT Lu-177-DOTATATE in Pancreatic Neuroendocrine Tumor Patients

Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

Monazzam, Azita; Li, Su-Chen; Wargelius, Hanna-Linn; Razmara, Masoud et al.

Part of Scientific Reports, 2020

• DOI for Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line
• Download full text (pdf) of Generation and characterization of CRISPR/Cas9-mediated MEN1 knockout BON1 cells: a human pancreatic neuroendocrine cell line

Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker

Ghosal, Suman; Das, Shaoli; Pang, Ying; Gonzales, Melissa K. et al.

Part of International Journal of Cancer, p. 2326-2335, 2020

• DOI for Long intergenic noncoding RNA profiles of pheochromocytoma and paraganglioma: A novel prognostic biomarker

Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation

Paulsson, Johan O.; Backman, Samuel; Wang, Na; Stenman, Adam et al.

Part of Journal of Pathology, p. 183-194, 2020

• DOI for Whole‐genome sequencing of synchronous thyroid carcinomas identifies aberrant DNA repair in thyroid cancer dedifferentiation

Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma

Jiang, Jingjing; Zhang, Jing; Pang, Yingxian; Bechmann, Nicole et al.

Part of Journal of Clinical Endocrinology and Metabolism, 2020

• DOI for Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma

High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Botling, Johan; Lamarca, Angela; Bajic, Duska; Norlén, Olov et al.

Part of Neuroendocrinology, p. 891-898, 2020

• DOI for High-grade progression confers poor survival in pancreatic neuroendocrine tumors

Whole genome sequencing of apparently mutation-negative MEN1 patients

Backman, Samuel; Bajic, Duska; Crona, Joakim; Hellman, Per et al.

Part of European Journal of Endocrinology, p. 35-45, 2020

• DOI for Whole genome sequencing of apparently mutation-negative MEN1 patients

C-11-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma

Vyakaranam, Achyut Ram; Crona, Joakim; Norlén, Olov; Hellman, Per et al.

Part of Cancers, 2019

• DOI for C-11-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma
• Download full text (pdf) of C-11-hydroxy-ephedrine-PET/CT in the Diagnosis of Pheochromocytoma and Paraganglioma

Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Vyakaranam, Achyut Ram; Crona, Joakim; Norlén, Olov; Granberg, Dan et al.

Part of Cancers, 2019

• DOI for Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.
• Download full text (pdf) of Favorable Outcome in Patients with Pheochromocytoma and Paraganglioma Treated with ¹⁷⁷Lu-DOTATATE.

Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study

Lamarca, Angela; Ronot, Maxime; Moalla, Salma; Crona, Joakim et al.

Part of Clinical Cancer Research, p. 6692-6699, 2019

• DOI for Tumour Growth Rate as a validated early radiological biomarker able to reflect treatment-induced changes in Neuroendocrine Tumours: the GREPONET-2 study

Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study

Lamarca, Angela; Crona, Joakim; Ronot, Maxime; Opalinska, Marta et al.

Part of The Oncologist, 2019

• DOI for Value of Tumor Growth Rate (TGR) as an Early Biomarker Predictor of Patients' Outcome in Neuroendocrine Tumors (NET): The GREPONET Study

Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.

Barbolosi, Dominique; Crona, Joakim; Serre, Raphaël; Pacak, Karel et al.

Part of PLOS ONE, 2018

• DOI for Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.
• Download full text (pdf) of Mathematical modeling of disease dynamics in SDHB- and SDHD-related paraganglioma: Further step in understanding hereditary tumor differences and future therapeutic strategies.

Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The Greponet Study

Lamarca, A.; Crona, Joakim; Ronot, M.; Opalinska, M. et al.

Part of Neuroendocrinology, p. 178-178, 2018

• DOI for Value of Tumor Growth Rate (TGR) as an Early Predictor of Patients' Outcome in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs): The Greponet Study

Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study

Crona, Joakim; Lamarca, A.; Ronot, M.; Opalinska, M. et al.

Part of Neuroendocrinology, p. 171-171, 2018

• DOI for Pre-Treatment Tumor Growth Rate (TGR0) in Patients Diagnosed with Well-Differentiated Neuroendocrine Tumors (NETs) Treated with Systemic Therapies: Subgroup Analysis of the GREPONET Study

RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

Crona, Joakim; Backman, Samuel; Welin, Staffan; Taieb, David et al.

Part of Cancers, 2018

• DOI for RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective
• Download full text (pdf) of RNA-Sequencing Analysis of Adrenocortical Carcinoma, Pheochromocytoma and Paraganglioma from a Pan-Cancer Perspective

Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations

Backman, Samuel; Maharjan, Rajani; Falk Delgado, Alberto; Crona, Joakim et al.

Part of Scientific Reports, 2017

• DOI for Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations
• Download full text (pdf) of Global DNA Methylation Analysis Identifies Two Discrete clusters of Pheochromocytoma with Distinct Genomic and Genetic Alterations

Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing

Backman, Samuel; Norlén, Olov; Eriksson, Barbro; Skogseid, Britt et al.

Part of Anticancer Research, p. 705-712, 2017

• DOI for Detection of Somatic Mutations in Gastroenteropancreatic Neuroendocrine Tumors Using Targeted Deep Sequencing

Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumors

Crona, Joakim; Norlén, Olov; Antonodimitrakis, Pantelis; Welin, Staffan et al.

Part of Pancreas, p. 441-441, 2017

• DOI for Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumors

An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors

Stålberg, Karin; Crona, Joakim; Razmara, Masoud; Taslica, Diana et al.

Part of International Journal of Gynecological Cancer, p. 1027-1032, 2016

• DOI for An Integrative Genomic Analysis of Formalin Fixed Paraffin-Embedded Archived Serous Ovarian Carcinoma Comparing Long-term and Short-term Survivors

Precision medicine in pheochromocytoma and paraganglioma: current and future concepts

Björklund, Peyman; Pacak, K.; Crona, Joakim

Part of Journal of Internal Medicine, p. 559-573, 2016

• DOI for Precision medicine in pheochromocytoma and paraganglioma: current and future concepts

Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours

Crona, Joakim; Norlén, Olov; Antonodimitrakis, Pantelis; Welin, Staffan et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 445-452, 2016

• DOI for Multiple and Secondary Hormone Secretion in Patients With Metastatic Pancreatic Neuroendocrine Tumours

Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma

Crona, Joakim; Ljungström, Viktor; Welin, Staffan; Walz, Martin K. et al.

Part of PLOS ONE, 2015

• DOI for Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma
• Download full text (pdf) of Bioinformatic Challenges in Clinical Diagnostic Application of Targeted Next Generation Sequencing: Experience from Pheochromocytoma

Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?

Delgado, Alberto Verdugo; Crona, Joakim; Maharjan, Rajani; Hellman, Per et al.

Part of Hormone and Metabolic Research, p. 452-455, 2015

• DOI for Exome Sequencing and CNV Analysis on Chromosome 18 in Small Intestinal Neuroendocrine Tumors: Ruling Out a Suspect?

Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors

Crona, Joakim; Gustavsson, Tobias; Norlén, Olov; Edfeldt, Katarina et al.

Part of Annals of Surgical Oncology, p. 1428-1435, 2015

• DOI for Somatic Mutations and Genetic Heterogeneity at the CDKN1B Locus in Small Intestinal Neuroendocrine Tumors

Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.

Crona, Joakim; Backman, Samuel; Maharjan, Rajani; Mayrhofer, Markus et al.

Part of Clinical Cancer Research, p. 4451-4460, 2015

• DOI for Spatiotemporal Heterogeneity Characterizes the Genetic Landscape of Pheochromocytoma and Defines Early Events in Tumorigenesis.

Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours

Crona, Joakim; Nordling, Margareta; Maharjan, Rajani; Granberg, Dan et al.

Part of PLOS ONE, 2014

• DOI for Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours
• Download full text (pdf) of Integrative Genetic Characterization and Phenotype Correlations in Pheochromocytoma and Paraganglioma Tumours

Global DNA methylation patterns in small intestinal neuroendocrine tumors (SI-NETs)

Delgado Verdugo, Alberto; Crona, Joakim; Starker, Lee F; Stålberg, Peter et al.

Part of Endocrine-Related Cancer, 2014

• DOI for Global DNA methylation patterns in small intestinal neuroendocrine tumors (SI-NETs)

Targeted Next Generation Sequencing in the Screening for Familial Neuroendocrine Tumor Syndromes: A Tool for Personalized Medicine

Crona, Joakim; Stålberg, Peter; Granberg, Dan; Welin, Staffan et al.

Part of Neuroendocrinology, p. 253-253, 2014

Secondary Hormonal Syndromes in Patients with Sporadic Neuroendocrine Tumors

Crona, Joakim; Eriksson, Barbro; Welin, Staffan

Part of Neuroendocrinology, p. 240-240, 2014

MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours

Crona, Joakim; Maharjan, Rajani; Delgado Verdugo, Alberto; Stålberg, Peter et al.

Part of Familial Cancer, p. 121-125, 2014

• DOI for MAX mutations status in Swedish patients with pheochromocytoma and paraganglioma tumours

Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma

Crona, Joakim; Verdugo, Alberto Delgado; Granberg, Dan; Welin, Staffan et al.

Part of Endocrine Connections, p. 104-111, 2013

• DOI for Next-generation sequencing in the clinical genetic screening of patients with pheochromocytoma and paraganglioma

Treatment, prognostic markers and survival in thymic neuroendocrine tumours: A study from a single tertiary referral centre

Crona, Joakim; Björklund, Peyman; Welin, Staffan; Kozlovacki, Gordana et al.

Part of Lung Cancer, p. 289-293, 2013

• DOI for Treatment, prognostic markers and survival in thymic neuroendocrine tumours: A study from a single tertiary referral centre

Effect of Temozolomide in Patients with Metastatic Bronchial Carcinoids

Crona, Joakim; Fanola, Irina; Lindholm, Daniel P.; Antonodimitrakis, Pantelis et al.

Part of Neuroendocrinology, p. 151-155, 2013

• DOI for Effect of Temozolomide in Patients with Metastatic Bronchial Carcinoids

Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing

Crona, Joakim; Verdugo, Alberto Delgado; Maharjan, Rajani; Stalberg, Peter et al.

Part of Journal of Clinical Endocrinology and Metabolism, 2013

• DOI for Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing

Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall?

Crona, Joakim; Granberg, Dan; Norlén, Olov; Wärnberg, Fredrik et al.

Part of World Journal of Surgery, p. 1701-1706, 2013

• DOI for Metastases from Neuroendocrine Tumors to the Breast Are More Common than Previously Thought. A Diagnostic Pitfall?

Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter

Åkerström, Tobias; Crona, Joakim; Verdugo, Alberto Delgado; Starker, Lee F. et al.

Part of PLOS ONE, 2012

• DOI for Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter
• Download full text (pdf) of Comprehensive Re-Sequencing of Adrenal Aldosterone Producing Lesions Reveal Three Somatic Mutations near the KCNJ5 Potassium Channel Selectivity Filter

Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

Taïeb, David; Nölting, Svenja; Perrier, Nancy D.; Fassnacht, Martin et al.

Part of Nature Reviews Endocrinology, p. 168-184, 2024

• DOI for Management of phaeochromocytoma and paraganglioma in patients with germline SDHB pathogenic variants: an international expert Consensus statement

Targeted Therapies in Pheochromocytoma and Paraganglioma

Wang, Katharina; Crona, Joakim; Beuschlein, Felix; Grossman, Ashley B. et al.

Part of Journal of Clinical Endocrinology and Metabolism, p. 2963-2972, 2022

• DOI for Targeted Therapies in Pheochromocytoma and Paraganglioma

Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma

Mollazadegan, Kazhan; Welin, Staffan; Crona, Joakim

Part of Current Treatment Options in Oncology, 2021

• DOI for Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma
• Download full text (pdf) of Systemic Treatment of Gastroenteropancreatic Neuroendocrine Carcinoma

ENSAT registry-based randomized clinical trials for adrenocortical carcinoma

Crona, Joakim; Baudin, Eric; Terzolo, Massimo; Chrisoulidou, Alexandra et al.

Part of European Journal of Endocrinology, 2021

• DOI for ENSAT registry-based randomized clinical trials for adrenocortical carcinoma

Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours

Dawod, Mohammed; Alonso Gordoa, Teresa; Cives, Mauro; De Mestier, Louis et al.

Part of Current Treatment Options in Oncology, 2021

• DOI for Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours

Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma

Muth, A.; Crona, Joakim; Gimm, O.; Elmgren, A. et al.

Part of Journal of Internal Medicine, p. 187-204, 2019

• DOI for Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma

Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Crona, Joakim; Lamarca, Angela; Ghosal, Suman; Welin, Staffan et al.

Part of Endocrine-Related Cancer, p. 539-550, 2019

• DOI for Genotype-phenotype correlations in pheochromocytoma and paraganglioma: a systematic review and individual patient meta-analysis

Adrenocortical carcinoma: towards genomics guided clinical care

Crona, Joakim; Beuschlein, Felix

Part of Nature Reviews Endocrinology, p. 548-560, 2019

• DOI for Adrenocortical carcinoma: towards genomics guided clinical care

Advances in adrenal tumors 2018

Crona, Joakim; Beuschlein, F.; Pacak, K.; Skogseid, Britt

Part of Endocrine-Related Cancer, 2018

• DOI for Advances in adrenal tumors 2018
• Download full text (pdf) of Advances in adrenal tumors 2018

New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification

Crona, Joakim; Taïeb, David; Pacak, Karel

Part of Endocrine reviews, p. 489-515, 2017

• DOI for New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification

Genetics of neuroendocrine tumors

Crona, Joakim; Skogseid, Britt

Part of European Journal of Endocrinology, 2016

• DOI for Genetics of neuroendocrine tumors

A review on management discussions of small intestinal neuroendocrine tumors 'midgut carcinoids'

Åkerström, Göran; Norlén, Olov; Edfeldt, Katarina; Crona, Joakim et al.

Part of INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, p. 119-128, 2015

• DOI for A review on management discussions of small intestinal neuroendocrine tumors 'midgut carcinoids'

Charting the Genetic Landscape and Clonal Architectures of Pheochromocytoma

Crona, Joakim

2014

• Download full text (pdf) of Charting the Genetic Landscape and Clonal Architectures of Pheochromocytoma

Multiregion Analysis Reveal Evolutionary Patterns and a Chromosomal Instability Signature in Pancreatic Neuroendocrine Tumours

Crona, Joakim; Backman, Samuel; Kugelberg, Johan; Maharjan, Rajani et al.

p. 6-6, 2016

Tumor Growth Rate in Pancreatic Neuroendocrine Tumor patients undergoing systemic therapies

Pettersson, Olof; Bernardo, Yvette; Crona, Joakim; Sundin, Anders